Garcia-Mouronte E, Naharro-Rodriguez J, Alonso-Mtz de Salinas L, Perez-Gonzalez L, Fernandez-Guarino M
Int J Mol Sci. 2025; 26(2).
PMID: 39859342
PMC: 11766313.
DOI: 10.3390/ijms26020628.
Poostiyan N, Barati M, Shahmoradi Z, Saber M
J Cosmet Dermatol. 2024; 24(2):e16676.
PMID: 39587989
PMC: 11845947.
DOI: 10.1111/jocd.16676.
Fredman G, Haedersdal M, Philipsen P, Andersen F, Bjerring P, Wiegell S
Acta Derm Venereol. 2024; 104:adv42190.
PMID: 39585185
PMC: 11609724.
DOI: 10.2340/actadv.v104.42190.
Bhatia N, Lain E, Jarell A, DuBois J, Tamarit M, Falques M
JAAD Int. 2024; 17:6-14.
PMID: 39268198
PMC: 11387381.
DOI: 10.1016/j.jdin.2024.07.001.
Valenti M, Bianco M, Narcisi A, Costanzo A, Borroni R, Ardigo M
Dermatol Pract Concept. 2024; 14(3 S1).
PMID: 39133636
PMC: 11566729.
DOI: 10.5826/dpc.1403S1a145S.
The "Personalising Actinic Keratosis Treatment for Immunocompromised Patients" (IM-PAKT) Project: An Expert Panel Opinion.
Szeimies R, Ulrich C, Ferrandiz-Pulido C, Hofbauer G, Lear J, Lebbe C
Dermatol Ther (Heidelb). 2024; 14(7):1739-1753.
PMID: 38902589
PMC: 11264500.
DOI: 10.1007/s13555-024-01215-y.
Vascular feature identification in actinic keratosis grades I-III using dynamic optical coherence tomography with automated, quantitative analysis.
Fredman G, Wiegell S, Haedersdal M, Untracht G
Arch Dermatol Res. 2024; 316(7):391.
PMID: 38878217
PMC: 11180023.
DOI: 10.1007/s00403-024-03022-z.
The development and validation of a decision aid to enhance shared decision-making for the management of actinic keratosis.
Brent G, Beardmore C, Mayers K, Barea A, Samarasinghe V, Pinder V
Skin Health Dis. 2024; 4(3):e388.
PMID: 38846696
PMC: 11150750.
DOI: 10.1002/ski2.388.
Digitally Enhanced Methods for the Diagnosis and Monitoring of Treatment Responses in Actinic Keratoses: A New Avenue in Personalized Skin Care.
Soare C, Cozma E, Celarel A, Rosca A, Lupu M, Voiculescu V
Cancers (Basel). 2024; 16(3).
PMID: 38339236
PMC: 10854727.
DOI: 10.3390/cancers16030484.
Evaluating the Efficacy and Safety of 4% 5-Fluorouracil Cream in Patients with Actinic Keratosis: An Expert Opinion.
Stockfleth E, Heppt M, Begeault N, Delarue A
Acta Derm Venereol. 2023; 103:adv11954.
PMID: 37982726
PMC: 10680462.
DOI: 10.2340/actadv.v103.11954.
The Promise of Semantic Segmentation in Detecting Actinic Keratosis Using Clinical Photography in the Wild.
Derekas P, Spyridonos P, Likas A, Zampeta A, Gaitanis G, Bassukas I
Cancers (Basel). 2023; 15(19).
PMID: 37835555
PMC: 10571759.
DOI: 10.3390/cancers15194861.
Expert Recommendations on Facilitating Personalized Approaches to Long-term Management of Actinic Keratosis: The Personalizing Actinic Keratosis Treatment (PAKT) Project.
Morton C, Baharlou S, Basset-Seguin N, Calzavara-Pinton P, Dirschka T, Gilaberte Y
Acta Derm Venereol. 2023; 103:adv6229.
PMID: 37289027
PMC: 10265500.
DOI: 10.2340/actadv.v103.6229.
Economic Evaluation of Tirbanibulin for the Treatment of Actinic Keratosis in Scotland.
Dymond A, Green W, Edwards M, Pont M, Gupta G
Pharmacoecon Open. 2023; 7(3):443-454.
PMID: 37012513
PMC: 10170011.
DOI: 10.1007/s41669-023-00410-5.
Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action.
Schlesinger T, Stockfleth E, Grada A, Berman B
Clin Cosmet Investig Dermatol. 2022; 15:2495-2506.
PMID: 36415541
PMC: 9675993.
DOI: 10.2147/CCID.S374122.
Attitudes among dermatologists regarding actinic keratosis treatment options.
Moretta G, Samela T, Sampogna F, Ricci F, Carlesimo F, Panebianco A
Dermatol Reports. 2022; 14(3):9392.
PMID: 36267162
PMC: 9577376.
DOI: 10.4081/dr.2022.9392.
Treatment of Actinic Keratosis: The Best Choice through an Observational Study.
Yoo S, Kim Y, Han J, Bang C, Park Y, Lee J
J Clin Med. 2022; 11(14).
PMID: 35887717
PMC: 9316230.
DOI: 10.3390/jcm11143953.
Actinic Keratoses (AK): An Exploratory Questionnaire-Based Study of Patients' Illness Perceptions.
Sgouros D, Milia-Argyti A, Arvanitis D, Polychronaki E, Kousta F, Panagiotopoulos A
Curr Oncol. 2022; 29(7):5150-5163.
PMID: 35877268
PMC: 9323725.
DOI: 10.3390/curroncol29070408.
Photodynamic Therapy with 5-Aminolevulinic Acid Patch for the Treatment of Actinic Keratosis.
Kiss N, Farkas K, Tosti G, De Gado F, Bergler-Czop B, Fazia G
J Clin Med. 2022; 11(11).
PMID: 35683551
PMC: 9181164.
DOI: 10.3390/jcm11113164.
Approaches to Field Therapy for Actinic Keratoses: Relating Clinical Trial Results to Real-world Practice-A Commentary.
Pariser D
J Clin Aesthet Dermatol. 2022; 15(4):40-43.
PMID: 35465033
PMC: 9017667.
Spontaneous regression rates of actinic keratosis: a systematic review and pooled analysis of randomized controlled trials.
Steeb T, Petzold A, Hornung A, Wessely A, Berking C, Heppt M
Sci Rep. 2022; 12(1):5884.
PMID: 35393452
PMC: 8990007.
DOI: 10.1038/s41598-022-09722-8.
